Skip to main content
PLOS One logoLink to PLOS One
. 2026 Mar 10;21(3):e0339241. doi: 10.1371/journal.pone.0339241

Benefit of urban greenness on patients after an ischaemic stroke: mortality or recurrence? A registry-based cohort study

Raphaël Anxionnat 1,2, Nadine Bernard 3, Anne-Sophie Mariet 4,5, Sophie Pujol 2,3, Anne-Laure Parmentier 2,3, Kadiatou Diallo 2, Hélène Houot 6, Théophile Pierre 2, Yannick Béjot 7, Frédéric Mauny 2,3,*
Editor: Redoy Ranjan8
PMCID: PMC12974875  PMID: 41805934

Abstract

Background

Whether living environment may influence outcome of stroke survivors remains to be elucidated.

Aim

This registry-based cohort study aimed to assess the relationship between urban greenness around the residence and one-year death or recurrence after a first-ever ischaemic stroke.

Methods

Patients with a first-ever ischaemic stroke who directly returned home were identified from the population-based registry of Dijon, France. For each patient, after geolocation of residential building, two greenness indices were calculated: the distance by road and pedestrian networks to the nearest public green space, and the area of green spaces within radii of 100 and 400 metres. Atmospheric NO2 and PM10 outdoor concentrations around the residence and deprivation index were assessed.

Results

During the 2005–2008 study period, 360 patients were identified and included (median age: 75 years-old (IQR: 63–83), 56% women). Fifteen died and 17 had recurrent stroke during the one year of follow-up. In adjusted models, the distance between public green spaces and patients’ residence was associated with stroke recurrence or death (HR = 1.26, 95% CI: 1.08–1.48, P < 0.01, for each 100 metre section of city network). In age-stratified analysis, this association remained significant only in patients aged 65–79 years (HR: 1.37, 95% CI: 1.10–1.71, P < 0.01). When considering separately stroke recurrence and death, this association remained significant for recurrence (HR = 1.30, 95% CI: 1.07–1.58, P < 0.01) but not for death (HR = 1.17, 95% CI: 0.89–1.52).

Conclusion

This study highlighted a beneficial influence of greenness on post-stroke recurrence in an urban area. These results indicate that urban planning policy could impact secondary prevention.

Introduction

Despite improvements in both prevention and acute management over the past decades, the burden of ischaemic stroke remains a major issue worldwide that will magnify in the coming years because of the ageing population and demographic transition [1], with survivors facing a substantial risk of recurrence and premature death. In addition to traditional vascular risk factors, increasing attention has been directed toward the role of environmental determinants of stroke. In a context of urbanization of lifestyles, with more than half of the world population living in urban areas, a substantial body of literature has pointed out an association between short- or long-term exposure to high ambient air pollution levels and ischaemic stroke occurrence [2,3]. Conversely, the impact of residential green space exposure on stroke burden has been less documented [4]. A few studies with heterogeneous design and population setting showed a protective association between green space exposure and either stroke incidence [511] or stroke-related mortality [1215]. Although largely hypothetical and multifactorial, proposed mechanisms underlying this association include improvements in cardiovascular and metabolic regulation (e.g., decreased heart rate and diastolic blood pressure [16]), reductions in primary atmospheric pollutants and noise, enhanced immune function [17,12], and promotion of physical and social activity [18]. The role of the human microbiota in autoimmune or inflammatory disorders has gradually been established [19,20], and its potential modulation through contact with green spaces has been suggested as a contributing factor [12].

Furthermore, a very limited number of studies focused on stroke survivors specifically, despite their heightened vulnerability to environmental influences in the context of secondary prevention. Hence, their findings suggested that green space exposure may result in a reduced risk of ischaemic stroke severity [21] or post-stroke disability [22].

Surprisingly, to the best of our knowledge, the risk of recurrence of ischaemic stroke in relation to proximity and accessibility to green spaces has not been studied.

To address this gap, this population-based study aimed to analyse the relationship between urban green spaces around the place of residence and one-year outcomes after a first-ever ischaemic stroke. We hypothesized that greater accessibility to urban greenness would be associated with a reduced risk of death and/or recurrence, independent of clinical, socioeconomic, and environmental confounders.

Methods

Study population

This study was based on data obtained from the Dijon Stroke Registry, an ongoing population-based registry [23] that complies with the defined criteria for conducting high-quality incidence stroke studies [24] and the guidelines for the reporting of incidence and prevalence studies in neuroepidemiology according to the Standards of Reporting of Neurological Disorders [25]. The methodology of the Dijon Stroke Registry has been detailed elsewhere [26]. Briefly, multiple overlapping sources of information are used to ensure exhaustive case collection of both hospitalised and nonhospitalised cases of stroke and transient ischaemic attack (TIA) among residents of the city of Dijon, eastern France (approximately 156,000 inhabitants currently). All identified cases were adjudicated by senior neurologists trained in stroke assessment according to the World Health Organisation diagnostic criteria [27]. For the present analysis, we only considered patients over 18 years old with first-ever ischaemic stroke who were registered between 01/01/2005 and 31/12/2008, for whom a valid postal address was available, and who were discharged home after hospitalisation or treated as outpatients.

Outcomes

The primary composite outcome was all-cause death or stroke recurrence at one year. Survival time was calculated from the date of the first stroke to the date of the first event occurrence (death or recurrence). Patients without any occurrence were censored at one year of follow-up. The secondary outcomes were all-cause death and stroke recurrence, which were considered separately.

Data collected

The following information was collected at registration: sex, age, residence address, and vascular risk factors. Stroke severity at onset was quantified using the National Institutes of Health Stroke Scale (NIHSS) score obtained at the first clinical examination or estimated retrospectively based on medical records and charts, as previously validated in the literature [28]. The aetiological classification of ischaemic stroke patients was performed by a stroke-trained neurologist investigator of the Dijon Stroke Registry based on medical records, including complementary exams performed during the diagnostic workup of ischaemic stroke, as follows: large artery atheroma, cardioembolic ischaemic stroke, lacunar ischaemic stroke due to small vessel disease, and ischaemic stroke from other or unidentified causes. Post-stroke disability was assessed via the modified Rankin scale (mRS) score at discharge from the acute care ward or immediately after stroke for outpatients [29]. Vital status data were collected by regularly checking death certificates obtained from the French national database.

We assessed the global accessibility of urban greenness via two indices: public greenness proximity and greenness density. The degree of public greenness proximity was calculated using a map of public green spaces provided by the mapping department of the Dijon metropolitan area (Grand Dijon). After the residential building was geolocated, it was quantified via spatial queries to calculate the distance (by road and pedestrian networks) between the place of residence of each participant and the nearest public green space. The greenness density was calculated via high-resolution satellite images (ORTHO-SAT SPOT) from the French National Geographic Institute to compute the modified soil-adjusted vegetation index (MSAVI) [30,31]. Compared to the normalised difference vegetation index (NDVI), MSAVI detects small vegetation patches [32] and is better adapted to urban green spaces [31]. This index was computed for the area of the walking and living neighborhood [33,34]. For each patient, we defined these areas using a circular buffer around the residence. According to Forsyth et al [35] and our previous studies [36,37], the area and percentage of green spaces were calculated within radii of 100 and 400 metres. The indices were assigned to each patient through their residential address at the date of the first stroke.

Outdoor air pollution exposure was assessed via emission/diffusion models. The method has been previously described [38,39]. Briefly, models were implemented by the regionally approved Air Quality Monitoring Association ATMO-Bourgogne Franche-Comté via Circul’Air® and ADMS-Urban® software. Two pollutants were considered: nitrogen dioxide (NO2) and fine particles with a diameter ≤ 10 mm (particulate matter or PM10). Air pollution models were validated via seasonal field measurements conducted by air quality monitoring agencies. To adjust for seasonal variations, monthly air pollutant concentrations were calculated. Maps of monthly concentrations expressed in micrograms per cubic metre (μg/m3) were available for each pollutant from January 2004 to December 2009, with a 2-metre per 2-metre resolution. For each patient, NO2 and PM10 exposure were quantified monthly in the immediate vicinity of the residential building (i.e., the average level within a 50 m radius of the home).

The socioeconomic level of the neighbourhood was estimated via an ecological index of disadvantage with a European vocation, the French DEPrivation index (FDEP). This index is based on four variables: the median income per consumption unit in the household, the percentage of high school graduates in the population aged over 15, the percentage of manual workers in the working population, and the unemployment rate [40]. The statistical unit was the IRIS (Îlots Regroupés pour l’Information Statistique), a geographical unit currently used by the French National Institute of Statistics and Economic Studies (INSEE) for population censuses, with approximately 2,000 individuals with relatively homogeneous social characteristics.

Statistical analysis

Descriptive data are presented as medians and interquartile ranges (IQRs) or means and standard deviations (SDs) for continuous variables or as frequencies and percentages for categorical variables. Multivariable analysis was performed with a Cox survival-type model, with time-varying variables for adjustment on atmospheric NO2 and PM10 exposure. Hazard ratios (HRs) and 95% confidence intervals (CIs) related to public greenness proximity were expressed for an increase in distance of 100 metres. The HR and 95% CI related to the greenness density within the 100- and 400-m radii were expressed for increases in the green space area of 1,000 and 10,000 m2, respectively. The analyses of the primary and secondary outcomes were adjusted for sex, age, FDEP, mRS score, and previous 30-day mean atmospheric pollutant concentrations. The significance threshold was set to 0.05. For all analyses, the hypotheses of proportional risks and the absence of marginal subjects, specific to the Cox model, were respected.

We performed a sensitivity analysis by stratifying age groups (<65, 65–79, and ≥80 years old) on the primary outcome and both public greenness proximity and greenness density.

All analyses were performed with R software version 4.1.0 (R Development Core Team, 2005), and the package survival was used for survival analyses, including time-varying exposure.

Ethics

This study is a retrospective analysis of data from the Dijon Stroke Registry, whose accreditation is regularly updated by national scientific or ethics boards: the French National Committee of Registers, the French Data Protection Authority (CNIL, number DR-2017–287), and the French Institute for Public Health Surveillance (Santé Publique France). According to the French legislation boards, the need for written patient consent was waived.

Results

Over the study period, among the 896 stroke cases recorded in the Dijon Stroke Registry, 360 patients with a first-ever ischaemic stroke were considered. After one year of follow-up, 30 subjects experienced a composite event (13 deaths and 17 recurrences). Among these subjects, two experienced a recurrence and died before the end of the one-year follow up. Regarding separate death and recurrence events, there were 15 and 17 deaths and recurrences.

The sociodemographic, clinical, and environmental characteristics of the patients are described in Table 1. Patients who presented a subsequent event (death or recurrence) were older (median age 81 years [IQR 74–87] vs. 74 years [IQR 63–82], p = 0.002) and had higher post-stroke mRS scores (median 2 [IQR 1–3] vs. 1 [IQR 0–2], p < 0.001). Other characteristics were broadly similar between the subjects. The nearest public green space (public greenness proximity) was located at 309 m on average, and the mean green space areas within 100 and 400 m of the patients’ residences (greenness density) were 2,900 and 51,000 m², which corresponded to proportions of 9% and 10%, respectively.

Table 1. Study population characteristics.

Variables Total subjects
n = 360
Event Censored
n = 330
P values c
Composite
n = 30a
Death
n = 15b
Recurrence
n = 17b
Sex
Men
Women

160 (44%)
200 (56%)

14 (47%)
16 (53%)

5 (33%)
10 (67%)

10 (59%)
7 (41%)

146 (44%)
184 (56%)

0.80
Age
Median age (IQR)
18–64
65-79
> 80

75 (63-83)
101 (28%)
131 (36%)
128 (36%)

81 (74-87)
4 (13%)
9 (30%)
17 (57%)

84 (80-88)
2 (13%)
2 (13%)
11 (74%)

80 (70-85)
2 (12%)
7 (41%)
8 (47%)

74 (63-82)
97 (29%)
122 (37%)
111 (34%)

0.002
0.03

Stroke severity
Median NIHSS score (IQR)
- Minor stroke [0–4]
- Moderate to severe stroke [5–42]
- NA
Median post-stroke mRS scored (IQR)

2 (2-4)
215 (80%)
53 (20%)
92
1 (0-2)

4 (2-6)
9 (64%)
5 (36%)
16
2 (1-3)

4 (2-14)
4 (57%)
3 (53%)
8
2 (1-3)

2 (2-4)
6 (75%)
2 (25%)
9
1 (0-3)

2 (2-4)
206 (81%)
48 (19%)
76
1 (0-2)

0.30
0.20


< 0.001
Etiological classification of (ischaemic) strokes
Atheromatous
Cardioembolic
Lacunar
Other


96 (27%)
75 (21%)
122 (34%)
67 (18%)


4 (13%)
10 (33%)
9 (30%)
7 (24%)


3 (20%)
6 (40%)
4 (27%)
2 (13%)


1 (6%)
4 (24%)
7 (41%)
5 (29%)


92 (28%)
65 (20%)
113 (34%)
60 (18%)


0.20


Vascular risk factors
Current hypertension
Current smoking
- NA
Hypercholesterolaemia
- NA
Diabetes
- NA
Atrial fibrillation
- NA

229 (64%)
93 (28%)
26
178 (50%)
1
48 (13%)
1
63 (18%)
1

21 (70%)
8 (30%)
3
14 (47%)

6 (20%)

10 (33%)

12 (80%)
4 (31%)
2
7 (47%)

5 (33%)

6 (40%)

10 (59%)
5 (31%)
1
8 (47%)

2 (12%)

4 (24%)

208 (63%)
85 (28%)
23
164 (50%)
1
42 (13%)
1
53 (16%)
1

0.40
0.80

0.70

0.30

0.018
French deprivation index FDEP
Median decile (IQR)
Favoured [1–4]
Mixed [5–7]
Unfavoured [8–10]

7 (5-8)
73 (32%)
171 (48%)
116 (32%)

7 (5-8)
4 (14%)
13 (43%)
13 (43%)

8 (6-9)
2 (13%)
4 (27%)
9 (60%)

7 (5-8)
3 (18%)
9 (53%)
5 (29%)

6 (5-8)
69 (21%)
158 (48%)
103 (31%)

0.14
0.30

Public greenness proximity: Mean (sd)
Nearest public green space by city network (in metres)
309 (192)
370 (246)
320 (144)
400 (300)
303 (185)
0.12
Greenness density: Mean (sd)
Within 100 metres of residence
- Area (× 1,000 m²)
- Proportion area (%)
Within 400 metres of residence
- Area (× 10,000 m²)
- Proportion area (%)


2.9 (3.3)
9 (10)

5.1 (4.5)
10 (9)


2.7 (4.5)
8 (14)

4.9 (4.8)
10 (10)


4.0 (5.2)
13 (17)

6.7 (5.8)
13 (11)


1.2 (3.1)
4 (10)

2.8 (2.7)
6 (5)


2.9 (3.1)
9 (10)

5.1 (4.4)
10 (9)


0.048
0.04

0.50
0.60
Air pollution (µg.m-3): Mean (sd)
NO2 concentrations
Previous 30 days
Previous 3 months


29.1 (7.5)
29.3 (7.0)


27.6 (7.1)
27.6 (6.8)


25.8 (6.9)
26.0 (7.3)


28.7 (7.0)
28.5 (6.4)


29.2 (7.5)
29.5 (7.1)


0.20
0.14
PM10 concentrations
Previous 30 days
Previous 3 months

18.9 (4.3)
19.1 (3.3)

19.2 (4.4)
18.8 (3.3)

19.3 (4.9)
19.3 (4.0)

18.8 (3.9)
18.1 (2.4)

18.9 (4.3)
19.1 (3.3)

0.70
0.40

a Primary outcome (13 death and 17 recurrences)

b Secondary outcomes

c Comparison between composite events (primary outcome) and censors

d Modified Rankin scale score

IQR: interquartile ranges

sd: standard deviations

The primary outcome (stroke recurrence or death) was associated with public greenness proximity (shown in Table 2). Hence, for each increase of 100 metres, the hazard ratios were 1.17 (95% CI: 1.01–1.37) after adjustment for sex and age (Model 2) and 1.26 (95% CI: 1.08–1.48) after additional adjustment for post-stroke mRS score, FDEP and PM10 concentrations (Model 5). No significant association was observed when the greenness density was considered, regardless of the area considered (within a radius of 100 or 400 metres around the residence) (Table 2).

Table 2. Primary outcome analyses (each greenness index was modelled separately).

Hazard ratio [95% confidence intervals] of green space variables on composite event risk after a first ischaemic stroke
Event = death and/or recurrence
Model 1
Crude
Composite event (n = 30)
Model 2
Model 1 +  sex, age
Model 3
Model 2 +  mRS score, FDEP
Model 4
Model 3 +  previous 30 day NO2 concentrations
Model 5
Model 3 +  previous 30 days PM10 concentrations
Public greenness proximity
Nearest public green space by city network a

Greenness density
Area of green space within 100 metres of residence b

Area of green space within 400 metres of residence c


1.17 [0.99, 1.37]



0.97 [0.86, 1.09]


0.99 [0.91, 1.07]


1.17 [1.01, 1.37] *



0.97 [0.87, 1.09]


1.1[0.91, 1.07]


1.27 [1.08, 1.49] **



0.98 [0.87, 1.10]


0.99 [0.90, 1.09]


1.30 [1.11, 1.53] **




0.95 [0.83, 1.07]



0.95 [0.86, 1.06]


1.26 [1.08, 1.48] **




0.96 [0.85, 1.09]



0.97 [0.88, 1.07]

a Expressed for an increase of 100 metres

b Expressed for an increase of 1,000 m²

c Expressed for an increase of 10,000 m²

FDEP: French deprivation index, mRS: modified Rankin scale

Values in bold mean that they are statistically significant

* P < 0.05

** P < 0.01

The results of the secondary outcome analyses are reported in Table 3. Whatever the model considered, there was a significant association between stroke recurrence and public greenness proximity. In addition, a higher greenness density, regardless of the area considered, was associated with a reduced risk of stroke recurrence. Conversely, no significant association was observed with death.

Table 3. Secondary outcomes analyses (each greenness index was modelled separately).

Death after a first ischaemic stroke
Hazard ratio [95% confidence interval]
of green space variables
Recurrence after a first ischaemic stroke
Hazard ratio [95% confidence interval]
of green space variables
Model A-1
Crude
Event: death (n = 15)
Model A-2
Model A-1 +
sex, age, mRS score, FDEP
Model A-3
Model A-2 +
previous 30 days PM10 concentrations
Model B-1
Crude
Event: recurrence (n = 17)
Model B-2
Model B-1 +  sex, age, mRS score, FDEP
Model B-3
Model B-2 + 
previous 30 days
PM10 concentrations
Public greenness proximity
Nearest public green space by city network a

Greenness density
Area of green space within 100 metres of residence b

Area of green space within 400 metres of residence c


1.04 [0.80, 1.36]



1.08 [0.96, 1.23]


1.06 [0.97, 1.16]


1.17 [0.90, 1.51]



1.09 [0.96, 1.25]


1.10 [0.98, 1.22]


1.17 [0.89, 1.52]





1.07 [0.93, 1.22]




1.06 [0.95, 1.19]


1.23 [1.02, 1.50] *




0.73 [0.54, 0.97] *



0.80 [0.66, 0.98] *


1.29 [1.07, 1.56] **




0.72 [0.54, 0.97] *



0.77 [0.61, 0.97] *


1.30 [1.07, 1.58] **




0.71 [0.53, 0.96] *



0.76 [0.60, 0.96] *

a Expressed for an increase of 100 metres

b Expressed for an increase of 1,000 m²

c Expressed for an increase of 10,000 m²

FDEP: French deprivation index, mRS: modified Rankin scale

Values in bold mean that they are statistically significant

* P < 0.05** P < 0.01

The results of the sensitivity analyses (according to age groups) are presented in Table 4. The highest HR related to public greenness proximity was observed for the 65–79-year-old age group. The greenness density did not reveal any association, regardless of the area considered.

Table 4. Age groups sensitivity analyses (each greenness index was modelled separately).

By age groups, HR [95% CI] of green space variables on composite event risk after a first ischaemic stroke
Event = death and/or recurrence
Models adjusted for sex, mRS score, FDEP, previous 30 days PM10 concentrations
≤ 64 years
(n event = 4)
65–79 years
(n event = 9)
≥ 80 years
(n event = 17)
Public greenness proximity
Nearest public green space by city network a

Greenness density
Area of green space within 100 metres of residence b

Area of green space within 400 metres of residence c

1.12 [0.66, 1.88]



1.16 [0.92, 1.48]


1.11 [0.95, 1.31]

1.37 [1.10, 1.71] **



0.92 [0.70, 1.21]


0.98 [0.80, 1.19]

1.18 [0.92, 1.50]



0.92 [0.77, 1.09]


0.87 [0.73, 1.04]

CI: Confidence IntervalHR: hazard ratioFDEP: French deprivation indexmRS: modified Rankin scale

a Expressed for an increase of 100 metres

b Expressed for an increase of 1,000 m²

c Expressed for an increase of 10,000 m²

Value in bold means that it is statistically significant

** P < 0.01

Discussion

This study demonstrated an association between a greater distance from urban public green spaces to the subjects’ residence and death and/or recurrence at one year in patients who returned home after a first-ever ischaemic stroke. This association was driven mainly by a higher risk of stroke recurrence and was particularly pronounced in patients aged 65–79 years.

This analysis was performed on data obtained from a population-based registry that provided exhaustive case collection. The patients were living in a middle-sized city, similar to the living conditions of 54% of the European population [41]. In the present analysis, we only considered patients who returned home after a stroke to avoid inaccurate assessment of environmental exposure by using an incorrect residential location (i.e., hospital, rehabilitation centre, etc.). Environmental exposures were directly assessed from the subjects’ geocoded addresses via an entirely reproducible process, and special attention was given to identifying the actual home building at the date of the first stroke instead of the last address recorded in the hospital information system. The modelling of exposure allowed a repeatable assessment, irrespective of the vital status of the patients.

Adjustment methods in multivariable analyses take into account the main potential confounding factors, such as sex, age, post-stroke mRS score, or FDEP. The relationship between socioeconomic status and accessibility to public green spaces could be considered complex. However, adjusting for FDEP did not alter the results, similarly to the adjustment for air pollution using a time-varying exposure Cox model [42].

We found that each 100-metre section of the city network between the subject’s residence and the nearest public green space increased the risk of death or recurrence by 26%. Our results are consistent with previous demonstrations of reduced mortality among stroke survivors living in greener areas, as reported in Boston [14], Ontario [10] and Catalonia [43]. In addition, three meta-analyses identified a similar effect, but they noted the heterogeneity of the studies and the indicators used [16,44,45].

Our results suggest a differential effect of greenness when recurrence and mortality are considered separately. The beneficial effect of proximity to green spaces from patients’ residences was greater and remained significant for stroke recurrence only. This could illustrate a mediating effect of stroke recurrence on the association between greenness and mortality. Moreover, the highest association was noted among the intermediate-aged 65–79-year-old patients. In France, the mean retirement age in 2007 was 61.1 years [46]. A French national study conducted over the same period revealed that the mobility of seniors decreased as their age increased [47]. Several French studies also reported that the percentage of time spent at home was approximately 95% among individuals aged over 65 years, with outdoor activities being restricted to less than 2% of daily life [48,49]. This time drastically decreased from people aged 65–74 years to people aged 75–84 years and people aged > 85 years. Specific data for individuals who had a stroke are not available. However, as we considered patients who returned directly home, i.e., those who had excellent or good immediate post-stroke recovery, as shown by a low post-stroke mRS score, it could be assumed that their lifestyle did not differ greatly from that of the general population. Subjects in the 65–79 years age group could have greater mobility than older subjects did, which could result in more effective access to green spaces. These potential modulations of the greenness effect by age should be considered when comparing results between studies, especially when age structures differ.

Several limitations must be acknowledged. The choice of this five-year period was guided by the need for homogeneity of the environment assessment. This period ended just before the construction of the Dijon tramway network in 2010, which induced major territorial, transportation, and atmospheric changes, limiting the study period to 2009, thus reducing the sample size, the follow-up period, and the number of patients with primary outcomes. Therefore, we cannot rule out the possibility of residual confounding factors. The small number of events in each age group limited additional analyses considering death or recurrence separately across age groups. The data did not allow the determination of the individual access to a private green space; this could have induced misclassification of the subjects having access to a private garden and who were associated with a low value of the greenness density index. The situation is prone to be rare. Finally, the identified relationships could differ across larger cities.

Perspectives

Larger prospective studies allowing stratified analyses would help to confirmed the results. They will allow exploration of the potential mechanisms involved, such as physical activity, stress reduction, or immune function. If so, it would be necessary to advocate in favour of the greening of urban spaces with decision-makers. Making active use of green spaces a part of prevention should also be included in the recommendations made to professionals in charge of the management of stroke patients. For a clinical perspective, encouraging the use of nearby green spaces may represent a simple, non-pharmacological complement to secondary prevention strategies.

To conclude, this study highlighted the beneficial influence of greenness on post-stroke outcomes in an urban area. The proximity to urban public green spaces from the place of residence and greenness density were associated with a reduced risk of recurrence after ischaemic stroke. These results indicate that in addition to medical strategies, urban planning policies, secondary prevention based on the use of nearby greenness could positively impact patients after stroke.

Acknowledgments

The authors acknowledge Mathieu Boilleaut from the local association for air quality monitoring Atmo Bourgogne Franche-Comté, Bérenger Martin and Clémence Courbot from CHU Besançon, Damien Roy from ThéMA laboratory. Computations for environmental exposure have been performed on the supercomputer facilities of the Mésocentre de calcul de Franche-Comté.

Data Availability

The data underlying this study contain potentially identifying and sensitive patient information. In particular, the use of geocoded residential data in a relatively small cohort could allow indirect identification of participants. Public sharing of these data is restricted by French regulations. Data are therefore available upon reasonable request sent to: Registre Dijonnais des AVC - Direction de la recherche clinique et de l’innovation - CHU Dijon Bourgogne 1 Boulevard Jeanne d’Arc 21079 DIJON Cedex, France recherche@chu-dijon.fr.

Funding Statement

NO2 pollution exposure assessment was supported by the Agence de l’Environnement et de la Maîtrise de l’Énergie (ADEME) [1217C0065] as part of the National Environmental Research and Occupational Health Program 2012 from the French Agency for Food, Environmental and Occupational Health and Safety (ANSES). PM10 pollution exposure assessment was supported by the Fondation de France (Engagement 00089823). The Dijon Stroke Registry was funded by Santé Publique France (French Institute for Public Health Surveillance), Institut national de la santé et de la recherche médicale (INSERM), and CHU Dijon Bourgogne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20:795–820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Shah ASV, Lee KK, McAllister DA, Hunter A, Nair H, Whiteley W, et al. Short term exposure to air pollution and stroke: systematic review and meta-analysis. BMJ. 2015;350:h1295. doi: 10.1136/bmj.h1295 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Alexeeff SE, Liao NS, Liu X, Van Den Eeden SK, Sidney S. Long-Term PM2.5 Exposure and Risks of Ischemic Heart Disease and Stroke Events: Review and Meta-Analysis. J Am Heart Assoc. 2021;10(1):e016890. doi: 10.1161/JAHA.120.016890 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Whyte M, Douwes J, Ranta A. Green space and stroke: A scoping review of the evidence. J Neurol Sci. 2024;457:122870. doi: 10.1016/j.jns.2024.122870 [DOI] [PubMed] [Google Scholar]
  • 5.Bao J, Cao Z, Huang C, Lei L, Yang Y, Peng J, et al. Modification effect of urban landscape characteristics on the association between heat and stroke morbidity: A small-scale intra-urban study in Shenzhen, China. Science of The Total Environment. 2021;786:147223. doi: 10.1016/j.scitotenv.2021.147223 [DOI] [Google Scholar]
  • 6.Servadio JL, Lawal AS, Davis T, Bates J, Russell AG, Ramaswami A, et al. Demographic Inequities in Health Outcomes and Air Pollution Exposure in the Atlanta Area and its Relationship to Urban Infrastructure. J Urban Health. 2019;96(2):219–34. doi: 10.1007/s11524-018-0318-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Jia X, Yu Y, Xia W, Masri S, Sami M, Hu Z, et al. Cardiovascular diseases in middle aged and older adults in China: the joint effects and mediation of different types of physical exercise and neighborhood greenness and walkability. Environ Res. 2018;167:175–83. doi: 10.1016/j.envres.2018.07.003 [DOI] [PubMed] [Google Scholar]
  • 8.Leng H, Li S, Yan S, An X. Exploring the Relationship between Green Space in a Neighbourhood and Cardiovascular Health in the Winter City of China: A Study Using a Health Survey for Harbin. Int J Environ Res Public Health. 2020;17(2):513. doi: 10.3390/ijerph17020513 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Poulsen AH, Sørensen M, Hvidtfeldt UA, Ketzel M, Christensen JH, Brandt J, et al. Air pollution and stroke; effect modification by sociodemographic and environmental factors. A cohort study from Denmark. Int J Hyg Environ Health. 2023;251:114165. doi: 10.1016/j.ijheh.2023.114165 [DOI] [PubMed] [Google Scholar]
  • 10.Paul LA, Hystad P, Burnett RT, Kwong JC, Crouse DL, van Donkelaar A, et al. Urban green space and the risks of dementia and stroke. Environ Res. 2020;186:109520. doi: 10.1016/j.envres.2020.109520 [DOI] [PubMed] [Google Scholar]
  • 11.Seo S, Choi S, Kim K, Kim SM, Park SM. Association between urban green space and the risk of cardiovascular disease: A longitudinal study in seven Korean metropolitan areas. Environ Int. 2019;125:51–7. doi: 10.1016/j.envint.2019.01.038 [DOI] [PubMed] [Google Scholar]
  • 12.Giacinto JJ, Fricker GA, Ritter M, Yost J, Doremus J. Urban forest biodiversity and cardiovascular disease: Potential health benefits from California’s street trees. PLoS One. 2021;16(11):e0254973. doi: 10.1371/journal.pone.0254973 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Wang D, Lau KK-L, Yu R, Wong SYS, Kwok TTY, Woo J. Neighbouring green space and mortality in community-dwelling elderly Hong Kong Chinese: a cohort study. BMJ Open. 2017;7(7):e015794. doi: 10.1136/bmjopen-2016-015794 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Wilker EH, Wu C-D, McNeely E, Mostofsky E, Spengler J, Wellenius GA, et al. Green space and mortality following ischemic stroke. Environ Res. 2014;133:42–8. doi: 10.1016/j.envres.2014.05.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Villeneuve PJ, Jerrett M, Su JG, Burnett RT, Chen H, Wheeler AJ, et al. A cohort study relating urban green space with mortality in Ontario, Canada. Environ Res. 2012;115:51–8. doi: 10.1016/j.envres.2012.03.003 [DOI] [PubMed] [Google Scholar]
  • 16.Twohig-Bennett C, Jones A. The health benefits of the great outdoors: A systematic review and meta-analysis of greenspace exposure and health outcomes. Environ Res. 2018;166:628–37. doi: 10.1016/j.envres.2018.06.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kuo M. How might contact with nature promote human health? Promising mechanisms and a possible central pathway. Front Psychol. 2015;6:1093. doi: 10.3389/fpsyg.2015.01093 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ranta A, Ozturk S, Wasay M, Giroud M, Béjot Y, Reis J. Environmental factors and stroke: Risk and prevention. J Neurol Sci. 2023;454:120860. doi: 10.1016/j.jns.2023.120860 [DOI] [PubMed] [Google Scholar]
  • 19.Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121–41. doi: 10.1016/j.cell.2014.03.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wang J, Zhang H, He J, Xiong X. The Role of the Gut Microbiota in the Development of Ischemic Stroke. Front Immunol. 2022;13:845243. doi: 10.3389/fimmu.2022.845243 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Vivanco-Hidalgo RM, Avellaneda-Gómez C, Dadvand P, Cirach M, Ois Á, Gómez González A, et al. Association of residential air pollution, noise, and greenspace with initial ischemic stroke severity. Environ Res. 2019;179(Pt A):108725. doi: 10.1016/j.envres.2019.108725 [DOI] [PubMed] [Google Scholar]
  • 22.Cao M, Guan T, Tong M, Li J, Lu H, Yang X, et al. Greenspace exposure and poststroke disability: A nationwide longitudinal study. Ecotoxicol Environ Saf. 2022;246:114195. doi: 10.1016/j.ecoenv.2022.114195 [DOI] [PubMed] [Google Scholar]
  • 23.Giroud M, Delpont B, Daubail B, Blanc C, Durier J, Giroud M, et al. Temporal Trends in Sex Differences With Regard to Stroke Incidence: The Dijon Stroke Registry (1987-2012). Stroke. 2017;48(4):846–9. doi: 10.1161/STROKEAHA.116.015913 [DOI] [PubMed] [Google Scholar]
  • 24.Feigin V, Norrving B, Sudlow CLM, Sacco RL. Updated Criteria for Population-Based Stroke and Transient Ischemic Attack Incidence Studies for the 21st Century. Stroke. 2018;49(9):2248–55. doi: 10.1161/STROKEAHA.118.022161 [DOI] [PubMed] [Google Scholar]
  • 25.Bennett DA, Brayne C, Feigin VL, Barker-Collo S, Brainin M, Davis D, et al. Development of the standards of reporting of neurological disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology. Eur J Epidemiol. 2015;30(7):569–76. doi: 10.1007/s10654-015-0034-5 [DOI] [PubMed] [Google Scholar]
  • 26.Béjot Y, Troisgros O, Gremeaux V, Lucas B, Jacquin A, Khoumri C, et al. Poststroke disposition and associated factors in a population-based study: the Dijon Stroke Registry. Stroke. 2012;43(8):2071–7. doi: 10.1161/STROKEAHA.112.658724 [DOI] [PubMed] [Google Scholar]
  • 27.The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol. 1988;41(2):105–14. doi: 10.1016/0895-4356(88)90084-4 [DOI] [PubMed] [Google Scholar]
  • 28.Williams LS, Yilmaz EY, Lopez-Yunez AM. Retrospective assessment of initial stroke severity with the NIH Stroke Scale. Stroke. 2000;31(4):858–62. doi: 10.1161/01.str.31.4.858 [DOI] [PubMed] [Google Scholar]
  • 29.Saver JL, Filip B, Hamilton S, Yanes A, Craig S, Cho M, et al. Improving the reliability of stroke disability grading in clinical trials and clinical practice: the Rankin Focused Assessment (RFA). Stroke. 2010;41(5):992–5. doi: 10.1161/STROKEAHA.109.571364 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Qi J, Chehbouni A, Huete AR, Kerr YH, Sorooshian S. A modified soil adjusted vegetation index. Remote Sensing of Environment. 1994;48(2):119–26. doi: 10.1016/0034-4257(94)90134-1 [DOI] [Google Scholar]
  • 31.Lee M, Kim S, Ha M. Community greenness and neurobehavioral health in children and adolescents. Sci Total Environ. 2019;672:381–8. doi: 10.1016/j.scitotenv.2019.03.454 [DOI] [PubMed] [Google Scholar]
  • 32.Van Delm A, Gulinck H. Classification and quantification of green in the expanding urban and semi-urban complex: Application of detailed field data and IKONOS-imagery. Ecological Indicators. 2011;11(1):52–60. doi: 10.1016/j.ecolind.2009.06.004 [DOI] [Google Scholar]
  • 33.Smith G, Gidlow C, Davey R, Foster C. What is my walking neighbourhood? A pilot study of English adults’ definitions of their local walking neighbourhoods. Int J Behav Nutr Phys Act. 2010;7:34. doi: 10.1186/1479-5868-7-34 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Chaix B, Merlo J, Evans D, Leal C, Havard S. Neighbourhoods in eco-epidemiologic research: delimiting personal exposure areas. A response to Riva, Gauvin, Apparicio and Brodeur. Soc Sci Med. 2009;69(9):1306–10. doi: 10.1016/j.socscimed.2009.07.018 [DOI] [PubMed] [Google Scholar]
  • 35.Forsyth A, Hearst M, Oakes JM, Schmitz KH. Design and Destinations: Factors Influencing Walking and Total Physical Activity. Urban Studies. 2008;45(9):1973–96. doi: 10.1177/0042098008093386 [DOI] [Google Scholar]
  • 36.Tenailleau QM, Bernard N, Pujol S, Houot H, Joly D, Mauny F. Assessing residential exposure to urban noise using environmental models: does the size of the local living neighborhood matter? J Expo Sci Environ Epidemiol. 2015;25(1):89–96. doi: 10.1038/jes.2014.33 [DOI] [PubMed] [Google Scholar]
  • 37.Tenailleau QM, Mauny F, Joly D, François S, Bernard N. Air pollution in moderately polluted urban areas: How does the definition of “neighborhood” impact exposure assessment? Environ Pollut. 2015;206:437–48. doi: 10.1016/j.envpol.2015.07.021 [DOI] [PubMed] [Google Scholar]
  • 38.Mariet A-S, Mauny F, Pujol S, Thiriez G, Sagot P, Riethmuller D, et al. Multiple pregnancies and air pollution in moderately polluted cities: Is there an association between air pollution and fetal growth? Environ Int. 2018;121(Pt 1):890–7. doi: 10.1016/j.envint.2018.10.015 [DOI] [PubMed] [Google Scholar]
  • 39.Mariet A-S, Bernard N, Pujol S, Sagot P, Thiriez G, Riethmuller D, et al. Association between moderated level of air pollution and fetal growth: the potential role of noise exposure. Sci Rep. 2021;11(1):11238. doi: 10.1038/s41598-021-90788-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Rey G, Rican S, Jougla E. Mesure des inégalités de mortalité par cause de décès. Approche écologique à l’aide d’un indice de désavantage social. Bulletin Epidémiologique Hebdomadaire. 2011. [Google Scholar]
  • 41.Giffinger R, Fertner C, Kramar H. City-ranking of European Medium-Sized Cities. Cent Reg Sci. 2007;9:1–12. [Google Scholar]
  • 42.Dekker FW, de Mutsert R, van Dijk PC, Zoccali C, Jager KJ. Survival analysis: time-dependent effects and time-varying risk factors. Kidney Int. 2008;74(8):994–7. doi: 10.1038/ki.2008.328 [DOI] [PubMed] [Google Scholar]
  • 43.Avellaneda-Gómez C, Vivanco-Hidalgo RM, Olmos S, Lazcano U, Valentin A, Milà C, et al. Air pollution and surrounding greenness in relation to ischemic stroke: A population-based cohort study. Environ Int. 2022;161:107147. doi: 10.1016/j.envint.2022.107147 [DOI] [PubMed] [Google Scholar]
  • 44.Liu X-X, Ma X-L, Huang W-Z, Luo Y-N, He C-J, Zhong X-M, et al. Green space and cardiovascular disease: A systematic review with meta-analysis. Environ Pollut. 2022;301:118990. doi: 10.1016/j.envpol.2022.118990 [DOI] [PubMed] [Google Scholar]
  • 45.Whyte M, Douwes J, Ranta A. Green space and stroke: A scoping review of the evidence. J Neurol Sci. 2024;457:122870. doi: 10.1016/j.jns.2024.122870 [DOI] [PubMed] [Google Scholar]
  • 46.Benallah S, Mette C. Âge moyen de départ en retraite: tendances récentes et évolutions attendues. Retraite et société. 2009;58:166–83. [Google Scholar]
  • 47.Pappalardo M, Armoogum J, Hubert J-P. La mobilité des Français panorama issu de l’enquête nationale transports et déplacements 2008. La Revue du CGDD. 2010;228. [Google Scholar]
  • 48.Insee. Seniors − France, portrait social. https://www.insee.fr/fr/statistiques/4238381?sommaire=4238781. 2019. Accessed 2025 December 19.
  • 49.Insee. Les activités des seniors: de moins en moins diversifiées passé 75 ans − France, portrait social. https://www.insee.fr/fr/statistiques/3646087?sommaire=3646226. 2018. Accessed 2025 December 21.
PLoS One. 2026 Mar 10;21(3):e0339241. doi: 10.1371/journal.pone.0339241.r001

Author response to Decision Letter 0


Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

18 Jan 2025

Decision Letter 0

Redoy Ranjan

6 Aug 2025

PONE-D-24-52535-->-->Benefit of urban greenness on patients after an ischaemic stroke: mortality or recurrence? A registry-based cohort study-->-->PLOS ONE?>

Dear Dr. Mauny,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 20 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Dr Redoy Ranjan, MBBS, MRCSEd, Ch.M., MS (CV&TS), FACS

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

3. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript.

4. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see

https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

We will update your Data Availability statement on your behalf to reflect the information you provide.

5. In the online submission form, you indicated that “Data cannot be shared publicly because of Europrean LEgacy restriction. Data are available from the CHU of Besancon (contact via the coresponding author) for researchers who meet the criteria for access to confidential data.”

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information .

7. Please remove all personal information, ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set.

Note: spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file.

Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data) and in the following article: http://www.bmj.com/content/340/bmj.c181.long .

8. Thank you for stating the following financial disclosure:

“NO2 pollution exposure assessment was supported by the Agence de l'Environnement et de la Maîtrise de l'Énergie (ADEME) [1217C0065] as part of the National Environmental Research and Occupational Health Program 2012 from the French Agency for Food, Environmental and Occupational Health and Safety (ANSES). PM10 pollution exposure assessment was supported by the Fondation de France

(Engagement 00089823). The Dijon Stroke Registry was funded by Santé Publique France (French Institute for Public Health Surveillance), Institut national de la santé et de la recherche médicale (INSERM), and CHU Dijon Bourgogne.”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

9. Thank you for stating the following in the Competing Interests section:

“NO2 pollution exposure assessment was supported by the Agence de l'Environnement et de la Maîtrise de l'Énergie (ADEME) [1217C0065] as part of the National Environmental Research and Occupational Health Program 2012 from the French Agency for Food, Environmental and Occupational Health and Safety (ANSES). PM10 pollution exposure assessment was supported by the Fondation de France

(Engagement 00089823). The Dijon Stroke Registry was funded by Santé Publique France (French Institute for Public Health Surveillance), Institut national de la santé et de la recherche médicale (INSERM), and CHU Dijon Bourgogne.”

We note that you received funding from a commercial source: BMS, Pfizer, Medtronic, Amgen, Servier,

NovoNordisk, Novartis

Please provide an amended Competing Interests Statement that explicitly states this commercial funder, along with any other relevant declarations relating to employment, consultancy, patents, products in development, marketed products, etc.

Within this Competing Interests Statement, please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include your amended Competing Interests Statement within your cover letter. We will change the online submission form on your behalf.

10. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Additional Editor Comments:

The authors are thanked for this submission to PLOS ONE. After a critical external peer review by three experts and considering the overall reviewers' comments, I recommend improving your paper's clarity and presentation based on recent literature and acknowledging reviewers' concerns. PLOS ONE's publication criteria consider methodological rigour and ethical standards, regardless of the paper's novelty.

[Note: HTML markup is below. Please do not edit.]

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: Reviewer comments for PLOS ONE (PONE-D-24-52535):

The authors demonstrated the beneficial effects of greenness on post-ischemic stroke recurrence patients in an urban area using a registry based cohort study. However, owing to the limited no. of a large amount of information such as theoretical, logically consistent (rational and research studies), statistical analysis, and survey database information does not get into my head (especially in the introduction, results, and discussion section). Based on the above limitation, I do have some major and minor concerns that should be addressed by the authors.

Major points-

1). Please add appropriate keywords related to this study and check keywords with abstract section content.

2). Introduction section is too short and needs to be elaborated.

3) Clearly state the research gap or knowledge deficit in the introduction section that the current study aims to address. Emphasize why investigating relationship between urban greeness and ischemic stroke patients is important and how it contributes to filling this gap in the literature.

4). Authors should maintain consistency, if once used abbreviation in the manuscript.

5). While conclusion section covers various aspects related to the beneficial effects of greenness on post-ischemic stroke recurrence patients in an urban area using a registry based cohort study, however authors should add as a suggestion, future research directions and clinical implications based on the findings of the current study.

6). Discussion section is too large. It is highly encouraged that the author should includes only relevant things with justify to results and also articles in discussion that can directly be correlated with the current study. Try to concise the discussion section.

Reviewer #2: As the age of strokes is getting older and stroke severity is becoming milder, research on recurrence after stroke is valuable. The authors' study showed the beneficial influence of greenness on post-stroke outcomes in an urban area, suggesting the importance of the living environment after stroke.

To complete this paper, I would like to offer some suggestions.

Regarding the last line on page 7, "The area and percentage of green spaces within radii of 100 and 400 metres around the 7places of residence were calculated for each patient," why was "The area and percentage of green spaces" decided to be "within radii of 100 and 400 metres"? It would be better to describe the reason why to deside "within radii of 100 and 400 metres".

Regarding the line 3-5 on page 10, "After one year of follow-up, there were 30 composite events (13 deaths and 17 recurrences). Regarding separate death and recurrence events, there were 15 and 17 deaths and recurrences," , were 2 of the 17 recurrences deaths?

Regarding lines 7-8 of the Results on page 10 “Patients who presented a subsequent event (death or recurrence) were older and had higher post-stroke mRS scores.”, I am unable to find data on higher post-stroke mRS scores. While this may be an oversight on my part, if the data is not listed, the authors should include it in the Results section.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes: HITESH S CHAOUHAN

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2026 Mar 10;21(3):e0339241. doi: 10.1371/journal.pone.0339241.r003

Author response to Decision Letter 1


12 Nov 2025

5. Review Comments to the Author

Reviewer #1: Reviewer comments for PLOS ONE (PONE-D-24-52535):

The authors demonstrated the beneficial effects of greenness on post-ischemic stroke recurrence patients in an urban area using a registry based cohort study. However, owing to the limited no. of a large amount of information such as theoretical, logically consistent (rational and research studies), statistical analysis, and survey database information does not get into my head (especially in the introduction, results, and discussion section). Based on the above limitation, I do have some major and minor concerns that should be addressed by the authors.

Major points-

1). Please add appropriate keywords related to this study and check keywords with abstract section content.

We removed the less relevant keywords and added one, all of which are present in the study abstract. Please see page 4. The list of the keywords includes : stroke, environmental health, cohort studies, greenness, population-based study. We deleted “neurology “ and “epidemiology”.

2). Introduction section is too short and needs to be elaborated.

In response to both point 2 and point 3, and as also requested by the second reviewer, we totally modified and expanded the Introduction part to address the importance of studying the outcomes of stroke survivors, the relevance of investigating the impact of greenness on stroke recurrence risk, and the pathophysiological mechanisms underlying the presumed effects. Please see page 4 to page 6.

3) Clearly state the research gap or knowledge deficit in the introduction section that the current study aims to address. Emphasize why investigating relationship between urban greenness and ischemic stroke patients is important and how it contributes to filling this gap in the literature.

We clarified these elements in the introduction section, as indicated in point 2 above.

4). Authors should maintain consistency, if once used abbreviation in the manuscript.

We revised the manuscript to ensure consistent use of abbreviations, for example “mRS” (modified Rankin Scale or post-stroke Rankin Scale), and removed unnecessary abbreviations to improve clarity.

5). While conclusion section covers various aspects related to the beneficial effects of greenness on post-ischemic stroke recurrence patients in an urban area using a registry based cohort study, however authors should add as a suggestion, future research directions and clinical implications based on the findings of the current study.

In response, we revised the conclusion section to add suggestions for future research directions and to highlight the potential clinical implications of our findings, including the encouragement of nearby green space use as part of secondary prevention strategies. The manuscript was modified as follows: page 14, Perspective part, lines 2-3 “They will enable exploration of the potential mechanisms involved, such as physical activity, stress reduction, or immune function.” and page 14-15, last two lines of the Perspective part “For a clinical perspective, encouraging the use of nearby green spaces may represent a simple, non-pharmacological complement to secondary prevention strategies.”

6). Discussion section is too large. It is highly encouraged that the author should include only relevant things with justify to results and also articles in discussion that can directly be correlated with the current study. Try to concise the discussion section.

The authors thanks for this comment. Indeed, the discussion part was not focused on the main topic of the results. We reduced the length of the discussion (from 82 lines to 61 lines). In response, and also to address points 2 and 3, we moved the discussion on the pathophysiological mechanisms to the Introduction, and reduced the sections on methodological biases, comparisons with studies reporting similar results, and explanations related to the study period. Please see page 12 to page 14.

Reviewer #2:

As the age of strokes is getting older and stroke severity is becoming milder, research on recurrence after stroke is valuable. The authors' study showed the beneficial influence of greenness on post-stroke outcomes in an urban area, suggesting the importance of the living environment after stroke. To complete this paper, I would like to offer some suggestions.

Regarding the last line on page 7, "The area and percentage of green spaces within radii of 100 and 400 metres around the places of residence were calculated for each patient," why was "The area and percentage of green spaces" decided to be "within radii of 100 and 400 metres"? It would be better to describe the reason why to deside "within radii of 100 and 400 metres".

In response, we revised the Methods section to clarify the rationale for defining greenness within 100- and 400-m radii. We provided more information and references considering the way the areas were defined, and explicated the living and the walking neighborhoods. We also inserted bibliographic references supporting this approach. The method part was modified as follows, page 8: ”This index was computed for the area of the walking and living neighborhood (ref Smith et al 2010; Choix et an 2009). For each patient, we defined these areas using a circular buffer around the residence. According to Forsyth et al (2008) and our previous studies (ref Tenailleau et al,2014 et 2015), the area and percentage of green spaces were defined calculated within radii of 100 and 400 metres.

Regarding the line 3-5 on page 10, "After one year of follow-up, there were 30 composite events (13 deaths and 17 recurrences). Regarding separate death and recurrence events, there were 15 and 17 deaths and recurrences," , were 2 of the 17 recurrences deaths?

We clarified this point at the beginning of the results section. Please see page 10, third line of the result part: ” After one year of follow-up, 30 subjects experienced a composite event (13 deaths and 17 recurrences). Among these subjects, two experienced a recurrence and died before the end of the one-year follow up”.

Regarding lines 7-8 of the Results on page 10 “Patients who presented a subsequent event (death or recurrence) were older and had higher post-stroke mRS scores.”, I am unable to find data on higher post-stroke mRS scores. While this may be an oversight on my part, if the data is not listed, the authors should include it in the Results section.

The information was not sufficiently clear; we have specified the values in the results section and renamed the variable as “Median post-stroke mRS score” in Table 1 (study population characteristics). Please see page 11, lines 2 to 5: “Patients who presented a subsequent event (death or recurrence) were older (median age 81 years [IQR 74–87] vs. 74 years [IQR 63–82], p = 0.002) and had higher post-stroke mRS scores (median 2 [IQR 1–3] vs. 1 [IQR 0–2], p < 0.001).”

Attachment

Submitted filename: Response to Reviewers.docx

pone.0339241.s002.docx (19KB, docx)

Decision Letter 1

Redoy Ranjan

3 Dec 2025

<p>Benefit of urban greenness on patients after an ischaemic stroke: mortality or recurrence? A registry-based cohort study

PONE-D-24-52535R1

Dear Dr. Mauny,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Redoy Ranjan, MS (CV&TS), Ch.M. (Edin), PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #2: Yes

**********

Reviewer #2: The authors have considered the comments I made in my review and have revised the manuscript appropriately.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #2: No

**********

Acceptance letter

Redoy Ranjan

PONE-D-24-52535R1

PLOS One

Dear Dr. Mauny,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Redoy Ranjan

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0339241.s002.docx (19KB, docx)

    Data Availability Statement

    The data underlying this study contain potentially identifying and sensitive patient information. In particular, the use of geocoded residential data in a relatively small cohort could allow indirect identification of participants. Public sharing of these data is restricted by French regulations. Data are therefore available upon reasonable request sent to: Registre Dijonnais des AVC - Direction de la recherche clinique et de l’innovation - CHU Dijon Bourgogne 1 Boulevard Jeanne d’Arc 21079 DIJON Cedex, France recherche@chu-dijon.fr.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES